These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35099302)

  • 1. Current Status and Emerging Options for Automated Insulin Delivery Systems.
    Forlenza GP; Lal RA
    Diabetes Technol Ther; 2022 May; 24(5):362-371. PubMed ID: 35099302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Future of Automated Insulin Delivery (AID) Systems.
    Garg SK; McVean JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
    [No Abstract]   [Full Text] [Related]  

  • 3. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and Emerging Technologies in Type 1 Diabetes.
    Sherwood JS; Russell SJ; Putman MS
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
    Klonoff DC; Shang T; Zhang J
    J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
    [No Abstract]   [Full Text] [Related]  

  • 10. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.
    Templer S
    Front Endocrinol (Lausanne); 2022; 13():919942. PubMed ID: 35733769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.
    Aaron RE; Tian T; Yeung AM; Huang J; Arreaza-Rubín GA; Ginsberg BH; Kompala T; Lee WA; Kerr D; Colmegna P; Mendez CE; Muchmore DB; Wallia A; Klonoff DC
    J Diabetes Sci Technol; 2024 Jan; 18(1):215-239. PubMed ID: 37811866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying Input Behaviors That Influence Clinical Outcomes in Diabetes and Other Chronic Illnesses.
    Lewis DM
    J Diabetes Sci Technol; 2022 May; 16(3):786-787. PubMed ID: 34971322
    [No Abstract]   [Full Text] [Related]  

  • 15. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated insulin dosing systems: Advances after a century of insulin.
    Thabit H; Lal R; Leelarathna L
    Diabet Med; 2021 Dec; 38(12):e14695. PubMed ID: 34547133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed-loop system in the management of diabetes: past, present, and future.
    Shah VN; Shoskes A; Tawfik B; Garg SK
    Diabetes Technol Ther; 2014 Aug; 16(8):477-90. PubMed ID: 25072271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated insulin delivery systems: from early research to routine care of type 1 diabetes.
    Renard E
    Acta Diabetol; 2023 Feb; 60(2):151-161. PubMed ID: 35994106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems.
    Lewis DM
    Diabet Med; 2022 May; 39(5):e14687. PubMed ID: 34510544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.